Gastro-oesophageal Reflux Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older
- People who have had reflux esophagitis (irritation and inflammation of the food pipe caused by stomach acid) confirmed by a camera examination of the stomach, graded as moderate to severe (LA grade B, C, or D)
- People who have been experiencing heartburn or acid reflux symptoms for at least 4 weeks before joining the trial
- People who are willing to give their agreement to participate and follow the study procedures
Who may not be able to join:
- People who have used the medications Vonaprazan or Esomeprazole in the past 4 weeks
- People who have previously had surgery on their food pipe or radiation treatment to that area
- People who have Barrett's esophagus (a change in the lining of the food pipe), a narrowing of the food pipe, or any cancer in that area
- Women who are pregnant or currently breastfeeding
- People with a history of acid reflux that did not respond to standard acid-reducing medications, or a condition where the stomach empties very slowly (severe gastroparesis)
- People with significant liver or kidney problems, based on specific blood and kidney function test results (confirm with trial site)
- People currently using anti-inflammatory painkillers (NSAIDs), steroids, or blood-thinning medications that may interfere with healing
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mohan Dr Ramchandani, MD DM, Asian Institute of Gastroenterology
Phone: 04023378888
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
• Endoscopic healing of reflux esophagitis at 8 weeks (defined as resolution of LA grade B, C, or D esophagitis).; Endoscopic healing of reflux esophagitis at 8 weeks (defined as resolution of LA grade B, C, or D esophagitis).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.